USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NOVASTERILIS, INC.
Address:
3109 N TRIPHAMMER RD
LANSING, NY
Phone:
N/A
URL:
N/A
EIN:
161589964
DUNS:
129172727
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $495,106.00 5
SBIR Phase II $2,780,258.00 3

Award List:

A NEW METHOD FOR STERILIZING BIOMEDICAL MATERIALS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$95,173.00
Agency:
HHS
Principal Investigator:
Abstract:
Description (provided by applicant): Development of novel biomedical sterilization technology is proposed. The method utilizes supercritical C02, which allows for the sterilization of materials that are incompatible with current methods. This technology can be applied to a variety of… More

Terminal Sterilization of Tendon Allografts with C02

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$99,996.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Terminal sterilization of tendon allografts to the same levels called for in medical devices is currently all but non-existent. Terminal sterilization using ethylene oxide gas leaves toxic residues and negatively impacts the probability of positive outcomes… More

A Method for Reduction of Bioburden in Bone Allografts

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A new method of bone tissue terminal sterilization using supercritical CO2 is proposed for accomplishing industrially acceptable levels of bacterial inactivation. Preliminary experiments reveal that unlike gamma-irradiation, supercritical CO2 does not reduce the… More

A Novel Method for Reduction of Bioburden in Bone Allografts - Phase II

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$916,853.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The direct result of phase I funding has been the development of a viable bone allograft terminal sterilization technology that will, for the first time, allow tissue banks to easily process bone tissue to a sterility assurance level equal to that called for in… More

SBIR Phase I: A New Vaccine Development Method

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$99,937.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I research project aims to develop a novel method for the production of whole cell vaccines using the supercritical CO2 technology. The majority of current whole cell vaccine preparations are made using formalin inactivation which has numerous… More

Terminal Sterilization of Tendon Allografts Using Supercritical CO2- Phase II

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$755,476.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Currently, most tissue banks use a two step process to sterilize soft tissue allografts. The initial step reduces the bioburden with the second step in sterilization resulting in terminal sterilization . The direct res ult of Phase 1 funding has been the… More

Feasibility of Supercritical Carbon Dioxide Sterilization for Absorbable Suture M

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
David C. Burns – 607-330-2772
Abstract:
DESCRIPTION (provided by applicant): Over the past several decades there has been relatively little innovation in the arena of medical device sterilization. Ethylene oxide (ETO) and gamma irradiation (3-irradiation) are the only technologies currently available for medical devices. In particular,… More

Feasibility of Supercritical Carbon Dioxide Sterilization for Absorbable Suture M

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,107,929.00
Agency:
HHS
Principal Investigator:
Janet L. Huie – 607-330-2772
Abstract:
DESCRIPTION (provided by applicant): Over the past several decades there has been relatively little innovation in the arena of medical device sterilization. Ethylene oxide (ETO) and gamma irradiation ( irradiation) are the only technologies commerciallyavailable for medical devices. In particular,… More